/, Interstitial Cystitis Network Blog/Popular IC Treatment Price Drops While Another Now Under Mylan Pharma Control

Popular IC Treatment Price Drops While Another Now Under Mylan Pharma Control

Hep-Lido-A Price Drops Dramatically

It’s not every day that you get a message from a company announcing that a price for a vital IC therapy has gone down but, believe it or not, it happened! Hep-Lido-A, the most popular bladder instillation in use for the treatment of interstitial cystitis, now costs just $25 per treatment. It was originally $90 per dose. That’s roughly an 80% decrease in price.

Produced by Imprimis PharmaceuticalsHep-Lido-A* is a compounded formulation of heparin and lidocaine that is instilled directly into the bladder as an immediate treatment option for patients with IC/PBS. In past years, many physicians made their own custom formulas and/or had patients blend ingredients for use with home instillations. Patients often complained about the cost of each individual ingredient, including a recent months long shortage of heparin.

Hep-Lido-A comes pre-mixed and packaged in a single kit. It’s ideal for patients who are doing home instillations and for doctors who don’t have the time to make custom instillations. It also reduces the potential for errors.  This is fantastic news!

Learn more about Hep-Lido-A at: http://www.defeatic.com

CystoProtek Now Under The Control of Mylan Pharmaceuticals! Yikes!

We are NOT thrilled to share that the supplement CystoProtek has fallen into the hands of Mylan Pharmaceuticals, the most unpopular pharmaceutical company in the USA at the moment due to their dramatic increase in price for the Epipen. Yes, it’s THAT company.

Mylan purchased Meda Consumer Health, the company that has US distribution rights for CystoProtek, on August 5, 2016.  We can only hope that they will not increase the price of this very popular and helpful supplement.

CystoProtek is still available through the ICN Shop. We get shipments each week and it frequently sells out.

We’ll try to keep you posted about any announcements or changes but, often, we’re the last to hear about product changes.




By |2016-09-12T17:21:52+00:00September 12th, 2016|Front Page Feed, Interstitial Cystitis Network Blog|Comments Off on Popular IC Treatment Price Drops While Another Now Under Mylan Pharma Control

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.